Publication | Open Access
CIRP promotes the progression of non-small cell lung cancer through activation of Wnt/β-catenin signaling via CTNNB1
47
Citations
41
References
2021
Year
Our results support CIRP as a candidate oncogene in NSCLC and a potential target for NSCLC therapy.
| Year | Citations | |
|---|---|---|
Page 1
Page 1